PA
DNLI icon

Parallel Advisors’s Denali Therapeutics DNLI Stock Holding History

Parallel Advisors’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.48K Sell
213
-145
-41% -$2.98K ﹤0.01% 3175
2026
Q1 		$6.87K Hold
358
– – ﹤0.01% 2916
2025
Q4 		$5.91K Sell
358
-76
-18% -$1.28K ﹤0.01% 2792
2025
Q3 		$6.3K Sell
434
-111
-20% -$1.59K ﹤0.01% 2692
2025
Q2 		$7.63K Buy
545
+383
+236% +$5.39K ﹤0.01% 2589
2025
Q1 		$2.2K Buy
162
+63
+64% +$1.21K ﹤0.01% 2952
2024
Q4 		$2.02K Sell
99
-13
-12% -$333 ﹤0.01% 2968
2024
Q3 		$3.26K Hold
112
– – ﹤0.01% 2753
2024
Q2 		$2.6K Sell
112
-304
-73% -$5.84K ﹤0.01% 2725
2024
Q1 		$8.54K Buy
416
+333
+401% +$6.26K ﹤0.01% 2372
2023
Q4 		$1.78K Sell
83
-237
-74% -$4.69K ﹤0.01% 2834
2023
Q3 		$6.6K Buy
320
+292
+1,043% +$7.41K ﹤0.01% 2382
2023
Q2 		$826 Sell
28
-3
-10% -$84 ﹤0.01% 2978
2023
Q1 		$714 Buy
+31
New +$853 ﹤0.01% 3028
2022
Q4 		– Sell
-10
Closed – – 3396
2022
Q3 		$0 Hold
10
– – ﹤0.01% 3222
2022
Q2 		$0 Buy
10
+8
+400% +$210 ﹤0.01% 3066
2022
Q1 		$0 Sell
2
-44
-96% -$1.51K ﹤0.01% 3038
2021
Q4 		$2K Buy
46
+20
+77% +$948 ﹤0.01% 2680
2021
Q3 		$1K Buy
+26
New +$1.47K ﹤0.01% 2840
2021
Q2 		– Sell
-12
Closed -$1K – 2958
2021
Q1 		$1K Hold
12
– – ﹤0.01% 2600
2020
Q4 		$1K Buy
+12
New +$725 ﹤0.01% 2412

Other funds holding DNLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Parallel Advisors's DNLI Position: Q2 2026 in Review

Parallel Advisors reduced its Denali Therapeutics (DNLI) stake by 41% in Q2 2026, selling an estimated $2.98K and leaving 213 shares worth $5.48K. The position accounts for ﹤0.01% of the portfolio, ranked #3175.

Parallel Advisors first reported a position in DNLI in Q4 2020 and has held it in 21 quarters since. The position peaked at $8.54K in Q1 2024. 112 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Parallel Advisors held 213 shares of Denali Therapeutics worth $5.48K as of Q2 2026.
  • Parallel Advisors sold 145 Denali Therapeutics shares in Q2 2026, an estimated $2.98K.
  • Denali Therapeutics made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3175 holding.
  • Parallel Advisors first reported a position in Denali Therapeutics in Q4 2020 and has held it in 21 quarters since.
  • Parallel Advisors's Denali Therapeutics position peaked at $8.54K in Q1 2024.
  • 112 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.